6-Formyl-prehnitenol | 96418-43-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 6-Formyl-prehnitenol
• 英文别名: 2-Hydroxy-3,4,5,6-tetramethylbenzaldehyde
• CAS: 96418-43-8
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: BOLMNCSVFQQKLQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• HEAT STORAGE MATERIAL AND HEAT UTILIZATION SYSTEM USING THE SAME
  申请人：Houjou Hirohiko

  公开号：US20120193570A1

  公开（公告）日：2012-08-02

  There is provided a heat storage material capable of recovering/storing thermal energy such as exhaust heat energy or sunlight, and a heat utilization system using the same. The heat storage material of the present invention comprises a complex compound of the formula (I), wherein, R, R′, A, B, C, D, A′, B′, C′ and D′ are as defined herein.

  提供一种热储存材料，能够恢复/储存热能，如废气热能或阳光能，以及使用该材料的热利用系统。本发明的热储存材料包括式（I）的复合物，其中，R、R′、A、B、C、D、A′、B′、C′和D′如本文所定义。
• Chroman Compounds
  申请人：Taugerbeck Andreas

  公开号：US20100102274A1

  公开（公告）日：2010-04-29

  The chroman compounds of the formula I according to the invention R 1 -(A 1 -Z 1 ) a —W 1 —(Z 2 -A 2 ) b -Z 3 —W 2 —(Z 4 -A 3 ) n -R 2 in which R 1 , A 1 , A 2 , A 3 , W 1 , W 2 , Z 1 , Z 2 , Z 3 , Z 4 , a, b and c have the meanings indicated in claim 1 , have two moieties W 1 and W 2 derived from chroman. The compounds are suitable as components of anisotropic switching media, as used, for example, in liquid-crystal display devices.

  根据本发明的公式I中的铬曼化合物，其化学结构为R1-(A1-Z1)a—W1—(Z2-A2)b-Z3—W2—(Z4-A3)n-R2，其中R1、A1、A2、A3、W1、W2、Z1、Z2、Z3、Z4、a、b和c的含义如权利要求书中所示，具有两个源自铬曼的分子W1和W2。这些化合物适用于各种各样的各向异性开关介质，例如液晶显示器件的组成部分。
• IRE-1alpha INHIBITORS
  申请人：MannKind Corporation

  公开号：US20140080832A1

  公开（公告）日：2014-03-20

  Compounds which directly inhibit IRE-1α activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.

  直接抑制IRE-1α活性的化合物、前药及其药学上可接受的盐。这些化合物和前药可用于治疗与未折叠蛋白应答相关的疾病，并可作为单一药物或联合治疗的组分。
• Medicinal Drug with Activity against Gram Positive Bacteria, Mycobacteria and Fungi
  申请人：LEVINA Elizabeth

  公开号：US20160000786A1

  公开（公告）日：2016-01-07

  The present invention discloses a nanocomposite material having single-walled aluminosilicate nanotube in polymer, a membrane comprising such nanocomposite material, and the method of making the nanocomposite material, in which the composite material has high volume fraction of well-dispersed nanotubes. A gel-phased single-walled aluminosilicate nanotube is first prepared and then mixed with a polymer matrix to yield the composite material.

  本发明披露了一种在聚合物中具有单壁氧化铝硅酸盐纳米管的纳米复合材料，以及包括这种纳米复合材料的膜和制备纳米复合材料的方法。该复合材料具有高体积分数的良好分散的纳米管。首先制备了凝胶相单壁氧化铝硅酸盐纳米管，然后与聚合物基体混合以得到复合材料。
• IRE-1alpha Inhibitors
  申请人：MannKind Corporation

  公开号：US20160168116A1

  公开（公告）日：2016-06-16

  Compounds which directly inhibit IRE-1α activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.